Sphingosine 1-Phosphate Receptor Modulator Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug (Fingolimod, Ozanimod, Siponimod, Ponesimod, Laquinimod); Application (Multiple Sclerosis, Ulcerative Colitis, Alzheimer's Disease) and Geography

Report Code: TIPRE00019077 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Sphingosine 1- Phosphate receptor modulator are the class of drug which belong to category of immunomodulatory agents and are used in treatment of multiple sclerosis. These drugs shows their action by binding with G- protein and SP-1 receptors. Immunomodulatory agents are used to regulate and normalize functioning of immune system.

MARKET DYNAMICS

The key market drivers for Sphingosine 1-Phosphate Receptor Modulator Market Includes, rising incidences of immunity disorders along with high prevalence of chronic disorders. Moreover, rising R&D investment by pharmaceutical companies to fill ANDA applications for developing novel therapies is also expected to fuel market growth. However, stringent regulations by drug regulating bodies and potential side effects from treatment is expected to restrain market growth during forecast period.

MARKET SCOPE

The "Sphingosine 1-Phosphate Receptor Modulator Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Sphingosine 1-Phosphate Receptor Modulator market with detailed market segmentation by drug and application. The Sphingosine 1-Phosphate Receptor Modulator Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Sphingosine 1-Phosphate Receptor Modulator Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Sphingosine 1-Phosphate Receptor Modulator Market is segmented on the basis of drug and application. On the basis of drug the market is segmented as, fingolimod, ozanimod, siponimod, ponesimod, laquinimod. And on the basis of application the market is segmented as, multiple sclerosis, ulcerative colitis, Alzheimer's disease.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Sphingosine 1-Phosphate Receptor Modulator Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Sphingosine 1-Phosphate Receptor Modulator Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Sphingosine 1-Phosphate Receptor Modulator Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Sphingosine 1-Phosphate Receptor Modulator Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Sphingosine 1-Phosphate Receptor Modulator Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Sphingosine 1-Phosphate Receptor Modulator Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Sphingosine 1-Phosphate Receptor Modulator market in the global market. Below mentioned is the list of few companies engaged in the Sphingosine 1-Phosphate Receptor Modulator Market.

The report also includes the profiles of key players in Sphingosine 1-Phosphate Receptor Modulator Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Novartis
  •   Bristol-Myers Squibb
  •   Celgene
  •   Sigma- Aldrich
  •   Teva api
  •   Dr. Reddy's
  •   Actelion Pharmaceuticals
  •   Johnson and Johnson
  •   Active Biotech
  •   Teva Pharma GmbH

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Sphingosine 1-Phosphate Receptor Modulator Market - By Drug
1.3.2 Sphingosine 1-Phosphate Receptor Modulator Market - By Application
1.3.3 Sphingosine 1-Phosphate Receptor Modulator Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR MARKET - GLOBAL MARKET ANALYSIS
6.1. SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR - GLOBAL MARKET OVERVIEW
6.2. SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR MARKET - REVENUE AND FORECASTS TO 2027 - DRUG
7.1. OVERVIEW
7.2. DRUG MARKET FORECASTS AND ANALYSIS
7.3. FINGOLIMOD
7.3.1. Overview
7.3.2. Fingolimod Market Forecast and Analysis
7.4. OZANIMOD
7.4.1. Overview
7.4.2. Ozanimod Market Forecast and Analysis
7.5. SIPONIMOD
7.5.1. Overview
7.5.2. Siponimod Market Forecast and Analysis
7.6. PONESIMOD
7.6.1. Overview
7.6.2. Ponesimod Market Forecast and Analysis
7.7. LAQUINIMOD
7.7.1. Overview
7.7.2. Laquinimod Market Forecast and Analysis
8. SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MULTIPLE SCLEROSIS
8.3.1. Overview
8.3.2. Multiple Sclerosis Market Forecast and Analysis
8.4. ULCERATIVE COLITIS
8.4.1. Overview
8.4.2. Ulcerative Colitis Market Forecast and Analysis
8.5. ALZHEIMER'S DISEASE
8.5.1. Overview
8.5.2. Alzheimer's Disease Market Forecast and Analysis

9. SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Sphingosine 1-Phosphate Receptor Modulator Market Overview
9.1.2 North America Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis
9.1.3 North America Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Drug
9.1.4 North America Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Application
9.1.5 North America Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Countries
9.1.5.1 United States Sphingosine 1-Phosphate Receptor Modulator Market
9.1.5.1.1 United States Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.1.5.1.2 United States Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.1.5.2 Canada Sphingosine 1-Phosphate Receptor Modulator Market
9.1.5.2.1 Canada Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.1.5.2.2 Canada Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.1.5.3 Mexico Sphingosine 1-Phosphate Receptor Modulator Market
9.1.5.3.1 Mexico Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.1.5.3.2 Mexico Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.2. EUROPE
9.2.1 Europe Sphingosine 1-Phosphate Receptor Modulator Market Overview
9.2.2 Europe Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis
9.2.3 Europe Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Drug
9.2.4 Europe Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Application
9.2.5 Europe Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Sphingosine 1-Phosphate Receptor Modulator Market
9.2.5.1.1 Germany Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.2.5.1.2 Germany Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.2.5.2 France Sphingosine 1-Phosphate Receptor Modulator Market
9.2.5.2.1 France Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.2.5.2.2 France Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.2.5.3 Italy Sphingosine 1-Phosphate Receptor Modulator Market
9.2.5.3.1 Italy Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.2.5.3.2 Italy Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.2.5.4 Spain Sphingosine 1-Phosphate Receptor Modulator Market
9.2.5.4.1 Spain Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.2.5.4.2 Spain Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.2.5.5 United Kingdom Sphingosine 1-Phosphate Receptor Modulator Market
9.2.5.5.1 United Kingdom Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.2.5.5.2 United Kingdom Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.2.5.6 Rest of Europe Sphingosine 1-Phosphate Receptor Modulator Market
9.2.5.6.1 Rest of Europe Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.2.5.6.2 Rest of Europe Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Sphingosine 1-Phosphate Receptor Modulator Market Overview
9.3.2 Asia-Pacific Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis
9.3.3 Asia-Pacific Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Drug
9.3.4 Asia-Pacific Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Sphingosine 1-Phosphate Receptor Modulator Market
9.3.5.1.1 Australia Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.3.5.1.2 Australia Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.3.5.2 China Sphingosine 1-Phosphate Receptor Modulator Market
9.3.5.2.1 China Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.3.5.2.2 China Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.3.5.3 India Sphingosine 1-Phosphate Receptor Modulator Market
9.3.5.3.1 India Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.3.5.3.2 India Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.3.5.4 Japan Sphingosine 1-Phosphate Receptor Modulator Market
9.3.5.4.1 Japan Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.3.5.4.2 Japan Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.3.5.5 South Korea Sphingosine 1-Phosphate Receptor Modulator Market
9.3.5.5.1 South Korea Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.3.5.5.2 South Korea Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.3.5.6 Rest of Asia-Pacific Sphingosine 1-Phosphate Receptor Modulator Market
9.3.5.6.1 Rest of Asia-Pacific Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.3.5.6.2 Rest of Asia-Pacific Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Sphingosine 1-Phosphate Receptor Modulator Market Overview
9.4.2 Middle East and Africa Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis
9.4.3 Middle East and Africa Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Drug
9.4.4 Middle East and Africa Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Sphingosine 1-Phosphate Receptor Modulator Market
9.4.5.1.1 South Africa Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.4.5.1.2 South Africa Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.4.5.2 Saudi Arabia Sphingosine 1-Phosphate Receptor Modulator Market
9.4.5.2.1 Saudi Arabia Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.4.5.2.2 Saudi Arabia Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.4.5.3 U.A.E Sphingosine 1-Phosphate Receptor Modulator Market
9.4.5.3.1 U.A.E Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.4.5.3.2 U.A.E Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.4.5.4 Rest of Middle East and Africa Sphingosine 1-Phosphate Receptor Modulator Market
9.4.5.4.1 Rest of Middle East and Africa Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.4.5.4.2 Rest of Middle East and Africa Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Sphingosine 1-Phosphate Receptor Modulator Market Overview
9.5.2 South and Central America Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis
9.5.3 South and Central America Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Drug
9.5.4 South and Central America Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Application
9.5.5 South and Central America Sphingosine 1-Phosphate Receptor Modulator Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Sphingosine 1-Phosphate Receptor Modulator Market
9.5.5.1.1 Brazil Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.5.5.1.2 Brazil Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.5.5.2 Argentina Sphingosine 1-Phosphate Receptor Modulator Market
9.5.5.2.1 Argentina Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.5.5.2.2 Argentina Sphingosine 1-Phosphate Receptor Modulator Market by Application
9.5.5.3 Rest of South and Central America Sphingosine 1-Phosphate Receptor Modulator Market
9.5.5.3.1 Rest of South and Central America Sphingosine 1-Phosphate Receptor Modulator Market by Drug
9.5.5.3.2 Rest of South and Central America Sphingosine 1-Phosphate Receptor Modulator Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR MARKET, KEY COMPANY PROFILES
11.1. NOVARTIS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BRISTOL-MYERS SQUIBB
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CELGENE
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SIGMA-ALDRICH
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. TEVA API
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. DR. REDDY'S
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ACTELION PHARMACEUTICALS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. JOHNSON AND JOHNSON
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ACTIVE BIOTECH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMA GMBH
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis
2. Bristol-Myers Squibb
3. Celgene
4. Sigma-Aldrich
5. Teva api
6. Dr. Reddy's
7. Actelion Pharmaceuticals
8. Johnson and Johnson
9. Active Biotech
10. Teva Pharma GmbH
TIPRE00019077
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking